When should we expect no residual tumor (pTO) once we submit incidental T1a-b prostate cancers to radical prostatectomy?
スポンサーリンク
概要
- 論文の詳細を見る
- 2011-02-01
著者
-
Freschi Massimo
Department Of Pathology Vita-salute University
-
Gallina Andrea
Department Of Urology Vita-salute San Raffaele
-
Salonia Andrea
Department Of Urology Vita-salute San Raffaele
-
Montorsi Francesco
Department Of Urology Vita-salute San Raffaele
-
Suardi Nazareno
Department Of Urology Vita-salute San Raffaele
-
Capitanio Umberto
Department Of Urology Vita-salute University San Raffaele
-
Rigatti Patrizio
Department Of Urology Vita-salute University
-
Rigatti Patrizio
Department Of Urology University Vita-salute Scientific Institute San Raffaele
-
Briganti Alberto
Department Of Urology Vita-salute San Raffaele
-
Montorsi Francesco
Department Of Urology Universita Vita-salute San Raffaele
-
Gallina Andrea
Department Of Urology University Vita-salute San Raffaele Hospital
-
Freschi Massimo
Department Of Pathology Scientific Institute Hospital San Raffaele
-
Briganti Alberto
Department Of Urology Vita Salute University/san Raffaele Hospital
-
Salonia Andrea
Department Of Urology University Vita-salute San Raffaele Hospital
-
Rigatti Patrizio
Department Of Urology University Vita-salute San Raffaele Hospital
-
CAPITANIO Umberto
Department of Urology and Urological Research Institute, University Vita-Salute, San Raffaele Hospital
-
RIGATTI Patrizio
Department of Urology and Urological Research Institute, University Vita-Salute, San Raffaele Hospital
-
MONTORSI Francesco
Department of Urology and Urological Research Institute, University Vita-Salute, San Raffaele Hospital
関連論文
- Vardenafil Improves Ejaculation Success Rates and Self-confidence in Men With Erectile Dysfunction due to Spinal Cord Injury
- Obesity does not increase the risk of lymph node metastases in patients with clinically localized prostate cancer undergoing radical prostatectomy and extended pelvic lymph node dissection
- The probability of Gleason score upgrading between biopsy and radical prostatectomy can be accurately predicted
- Effect of body mass index on prostate-specific antigen and percentage free prostate-specific antigen : Results from a prostate cancer screening cohort of 1490 men
- A nomogram predicting metastatic progression after radical prostatectomy
- General versus spinal anesthesia with different forms of sedation in patients undergoing radical retropubic prostatectomy : Results of a prospective, randomized study
- Is extended and saturation biopsy necessary?
- When should we expect no residual tumor (pTO) once we submit incidental T1a-b prostate cancers to radical prostatectomy?
- Lymph node count threshold for optimal pelvic lymph node staging in prostate cancer
- Comparison of mortality outcomes after radical prostatectomy versus radiotherapy in patients with localized prostate cancer : A population-based analysis
- Editorial Comment to Risk factors for pelvic lymphoceles post-radical prostatectomy
- Leydig cell tumor of the spermatic cord in an adolescent affected by congenital adrenal hyperplasia
- Comparison of the response to treatment between Asian and Caucasian men with benign prostatic hyperplasia : Long-term results from the combination of dutasteride and tamsulosin study
- Oncological outcomes after radical nephroureterectomy for upper tract urothelial carcinoma : Comparison over the three decades
- Postoperative phosphodiesterase type 5 inhibitor administration increases the rate of urinary continence recovery after bilateral nerve-sparing radical prostatectomy